CERVAVAC

Cervavac Injection consists of the active constituent Human Papilloma Virus vaccine. It is indicated to protect your body against infections and diseases caused by the human papillomavirus types 6, 11, 16, and 18. These virus types cause diseases like pre-cancerous lesions in the female genital areas (cervix, vulva, vagina) and anal regions and cause genital warts in males and females.

HPV types 16 and 18 are responsible for approximately 70-80% of cervical and anal cancer cases, and HPV types 6 and 11 are responsible for almost 90 % of genital wart cases.

The HPV virus is a common sexually transmitted infection that can lead to various health problems, including genital warts and various types of cancer, including cervical, anal, penile, and throat cancer. Cervavac Injection does not cure the disease; it protects against it. It does not affect people who are already infected with the virus. This vaccine is only intended to prevent these diseases. The Cervavac vaccine age limit is generally between 9 and 26 years. However, always talk with your doctor first if you have any complications.

Cervavac vaccine is most effective when given before a person becomes sexually active, as it is designed to protect against HPV strains commonly transmitted through sexual contact. Cervavac Injection is generally considered safe and effective and has been shown to significantly reduce the risk of HPV-related health problems. There are no known interactions with other vaccines.